Taking It Upstream: Toward Unraveling the Mystery of Aneurysms in Apical Hypertrophic Cardiomyopathy.

[1]  L. Axel,et al.  Apical Aneurysms and Mid-Left Ventricular Obstruction in Hypertrophic Cardiomyopathy. , 2023, JACC. Cardiovascular imaging.

[2]  N. Smedira,et al.  Myosin Inhibition and Left Ventricular Diastolic Function in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Insights From the VALOR-HCM Study , 2022, Circulation. Cardiovascular imaging.

[3]  M. Desai,et al.  Dose-Blinded Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Outcomes Through 32 Weeks , 2022, Circulation.

[4]  R. Chan,et al.  Clinical Characteristics and Prognostic Importance of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy. , 2022, JACC. Cardiovascular imaging.

[5]  N. Smedira,et al.  Apical myectomy in HCM: Time to let the rubber of the operation meet the road of a randomized trial. , 2022, The Annals of thoracic surgery.

[6]  Matthew W. Martinez,et al.  2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. , 2020, Circulation.

[7]  S. Ommen,et al.  Early Outcomes of Repair of Left Ventricular Apical Aneurysms in Patients With Hypertrophic Cardiomyopathy. , 2017, Circulation.

[8]  J. Zamorano,et al.  Clinical practice of contrast echocardiography: recommendation by the European Association of Cardiovascular Imaging (EACVI) 2017. , 2017, European heart journal cardiovascular Imaging.

[9]  M. Link,et al.  Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm: Implications for Risk Stratification and Management. , 2017, Journal of the American College of Cardiology.

[10]  R. Chan,et al.  Prognostic Value of LGE-CMR in HCM: A Meta-Analysis. , 2016, JACC. Cardiovascular imaging.

[11]  C. Appleton,et al.  The Incremental Value of Magnetic Resonance Imaging for Identification of Apical Pouch in Patients with Apical Variant of Hypertrophic Cardiomyopathy , 2016, Echocardiography.

[12]  F. Rutten,et al.  2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). , 2014, European heart journal.

[13]  W. Manning,et al.  Response to Letter Regarding Article, “Prevalence, Clinical Significance, and Natural History of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy” , 2009 .

[14]  T. Kuribayashi,et al.  Sustained cavity obliteration and apical aneurysm formation in apical hypertrophic cardiomyopathy. , 2003, Journal of the American College of Cardiology.

[15]  M. Eriksson,et al.  Long-term outcome in patients with apical hypertrophic cardiomyopathy. , 2002, Journal of the American College of Cardiology.